Karen E. Mark

1.1k total citations
21 papers, 798 citations indexed

About

Karen E. Mark is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Karen E. Mark has authored 21 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Karen E. Mark's work include Herpesvirus Infections and Treatments (13 papers), HIV/AIDS Research and Interventions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Karen E. Mark is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), HIV/AIDS Research and Interventions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Karen E. Mark collaborates with scholars based in United States, Canada and United Kingdom. Karen E. Mark's co-authors include Anna Wald, Lawrence Corey, Stacy Selke, Amalia Magaret, Meei‐Li Huang, Joshua T. Schiffer, Jia Zhu, Laith J. Abu‐Raddad, David M. Koelle and Robert A. Gunn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Karen E. Mark

20 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen E. Mark United States 13 577 190 178 160 74 21 798
Alexander J. Ryncarz United States 6 670 1.2× 91 0.5× 196 1.1× 155 1.0× 118 1.6× 8 787
Richard P. DiCarlo United States 10 527 0.9× 123 0.6× 105 0.6× 101 0.6× 159 2.1× 19 779
Dereck Tait South Africa 13 620 1.1× 179 0.9× 389 2.2× 78 0.5× 90 1.2× 23 1.0k
Arvid Nilsen Norway 13 479 0.8× 83 0.4× 149 0.8× 65 0.4× 97 1.3× 27 658
Michael Remington United States 16 1.2k 2.1× 235 1.2× 327 1.8× 216 1.4× 165 2.2× 20 1.5k
Jean‐Elie Malkin France 14 547 0.9× 65 0.3× 319 1.8× 178 1.1× 132 1.8× 45 863
P E Munday United Kingdom 20 554 1.0× 123 0.6× 197 1.1× 90 0.6× 334 4.5× 57 1.0k
Diana Hardie South Africa 19 624 1.1× 75 0.4× 447 2.5× 117 0.7× 30 0.4× 44 947
M. Dillon United States 11 479 0.8× 97 0.5× 291 1.6× 236 1.5× 42 0.6× 14 749
D J Jeffries United Kingdom 15 319 0.6× 308 1.6× 314 1.8× 225 1.4× 27 0.4× 27 919

Countries citing papers authored by Karen E. Mark

Since Specialization
Citations

This map shows the geographic impact of Karen E. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Mark more than expected).

Fields of papers citing papers by Karen E. Mark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Mark. The network helps show where Karen E. Mark may publish in the future.

Co-authorship network of co-authors of Karen E. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Mark. A scholar is included among the top collaborators of Karen E. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Mark. Karen E. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Aleda M.H., Stacy D. Brown, Karen E. Mark, & Sarah McBane. (2023). An overview of Instructional approaches and decision-making strategies to curtail curricular overload. American Journal of Pharmaceutical Education. 87(8). 100013–100013. 15 indexed citations
2.
Wilken, Jason A., Janet N. Arno, Robert J. Harrison, et al.. (2016). Occupational HIV Transmission Among Male Adult Film Performers — Multiple States, 2014. MMWR Morbidity and Mortality Weekly Report. 65(5). 110–114. 6 indexed citations
3.
Mark, Karen E., Spotswood L. Spruance, G R Kinghorn, et al.. (2014). Three Phase III Randomized Controlled Trials of Topical Resiquimod 0.01-Percent Gel To Reduce Anogenital Herpes Recurrences. Antimicrobial Agents and Chemotherapy. 58(9). 5016–5023. 6 indexed citations
4.
Scheer, Susan, et al.. (2013). Estimated HIV Incidence in California, 2006–2009. PLoS ONE. 8(2). e55002–e55002. 8 indexed citations
5.
6.
Barnabas, Ruanne V., Judith N. Wasserheit, Yunda Huang, et al.. (2011). Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study). JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(3). 238–244. 55 indexed citations
7.
Barnabas, Ruanne V., Judith N. Wasserheit, Yunda Huang, et al.. (2011). Impact of Herpes Simplex Virus Type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step Study). JAIDS Journal of Acquired Immune Deficiency Syndromes. 1–1. 5 indexed citations
8.
Mark, Karen E., Anna Wald, Amalia Magaret, et al.. (2010). Rapidly Cleared Episodes of Oral and Anogenital Herpes Simplex Virus Shedding in HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 482–488. 30 indexed citations
9.
Schiffer, Joshua T., Laith J. Abu‐Raddad, Karen E. Mark, et al.. (2010). Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proceedings of the National Academy of Sciences. 107(44). 18973–18978. 92 indexed citations
10.
Schiffer, Joshua T., Laith J. Abu‐Raddad, Karen E. Mark, et al.. (2009). Frequent Release of Low Amounts of Herpes Simplex Virus from Neurons: Results of a Mathematical Model. Science Translational Medicine. 1(7). 7ra16–7ra16. 95 indexed citations
11.
Mark, Karen E., Anna Wald, Amalia Magaret, et al.. (2008). Rapidly Cleared Episodes of Herpes Simplex Virus Reactivation in Immunocompetent Adults. The Journal of Infectious Diseases. 198(8). 1141–1149. 189 indexed citations
12.
Mark, Karen E., et al.. (2008). Internet and Email Use Among STD Clinic Patients. Sexually Transmitted Diseases. 35(11). 960–965. 11 indexed citations
13.
Crane, Heidi M., Greg E. Davis, Karen E. Mark, & Robert Harrington. (2008). Tympanic Membrane Perforation:An Unusual Complication of Varicella-Zoster Virus Infection.
14.
Mark, Karen E., Lawrence Corey, Tze‐Chiang Meng, et al.. (2007). Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 195(9). 1324–1331. 78 indexed citations
15.
Mark, Karen E., et al.. (2007). Medical Care and Alcohol Use after Testing Hepatitis C Antibody Positive at STD Clinic and HIV Test Site Screening Programs. Public Health Reports. 122(1). 37–43. 12 indexed citations
16.
Mark, Karen E., Jareen Meinzen‐Derr, Rob Stephenson, et al.. (2007). Contraception among HIV Concordant and Discordant Couples in Zambia: A Randomized Controlled Trial. Journal of Women s Health. 16(8). 1200–1210. 55 indexed citations
17.
Mark, Karen E.. (2006). Almost Half of Genital HSV-2 Reactivations Last 6 Hours or Less. 1 indexed citations
18.
Mark, Karen E., et al.. (2006). Targeted prenatal herpes simplex virus testing: Can we identify women at risk of transmission to the neonate?. American Journal of Obstetrics and Gynecology. 194(2). 408–414. 27 indexed citations
19.
Hayes, John M., José G. Rigau-Pérez, Paul Reiter, et al.. (2005). Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(6). 559–566. 19 indexed citations
20.
Mark, Karen E. & Robert A. Gunn. (2004). Gonorrhea Surveillance. Sexually Transmitted Diseases. 31(4). 215–220. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026